Systems-Level Cancer Gene Identification from Protein Interaction Network Topology
Recent research from the United States has demonstrated that analyzing the structural properties of protein-protein interaction (PPI) networks can provide insights into biological function and disease, including cancer. By applying a series of clustering methods to proteins' topological signature similarities, researchers were able to identify novel cancer gene candidates, with 80% of their predictions validated in the literature. This study highlights the potential of PPI network topology in understanding complex diseases and identifying new therapeutic targets.
Key Takeaways:
- Researchers used a graph theoretic method called "graphlet degree signatures" to compare the topologies of node neighborhoods in PPI networks, demonstrating that proteins with similar surroundings tend to perform the same functions.
- The study applied clustering methods to proteins' topological signature similarities, resulting in clusters that were significantly enriched with cancer genes.
- The researchers validated 80% of their predictions in the literature, providing evidence for the power of PPI network topology in identifying novel cancer gene candidates.
- The study highlighted the potential of PPI network topology in understanding complex diseases and identifying new therapeutic targets.
- The researchers identified cancer-related negative regulators of melanogenesis using a siRNA screen, validating their predictions biologically.
- The study demonstrated that PPI network structure around cancer genes is different from the structure around non-cancer genes.
- The researchers suggested that understanding the underlying principles of this phenomenon has the potential to increase our understanding of complex diseases.
- The study provides clear evidence that PPI network topology can be used to identify novel cancer gene candidates and provide insights into biological function and disease.
Statistics:
- 80% of predictions made by the researchers were validated in the literature.
- The study identified cancer-related negative regulators of melanogenesis using a siRNA screen.
- The researchers demonstrated that PPI network structure around cancer genes is different from the structure around non-cancer genes.
- 201,000 people die each year from melanoma in the United States alone.
Sources:
- Journal of the Royal Society, Interface, 2010;7(44):423-37
- Cancer Gene Therapy
- Gene Therapy Weekly
- University of California, Department of Computer Science
- NewsRx.com
- T. Milenkovic, et al., University of California, Department of Computer Science (Irvine, CA 92697-3435 USA)